Skip to content

Clinical trials

Phase 3 Rubella trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Rubella Phase: Phase 3 Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20021
20041
20053
20065
20074
20083
20091
20101
20124
20142
20151
20232
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed31
Not yet recruiting2
Unknown status2
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Merck Sharp & Dohme LLC14
GlaxoSmithKline13
Sanofi Pasteur, a Sanofi Company4
International Centre for Diarrhoeal Disease Research, Bangladesh2
Novartis Vaccines1
Shanghai Institute Of Biological Products1
The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)1
University of Zurich1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Measles37
Rubella37
Mumps35
Chickenpox28
Haemophilus Infections4
Meningitis, Meningococcal3
Cholera1
Diphtheria1
Encephalitis, Japanese1
Hepatitis B1

Trials

Showing 26 to 37 of 37. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.